The promise of the bioeconomy has never been greater. Advances in biotechnology, fermentation, synthetic biology, and bioprocess engineering are creating new pathways to produce materials, chemicals, ingredients, and fuels from renewable resources. Global demand for sustainable alternatives continues to grow, investors are directing capital toward cutting edge R&D, and governments around the world are supporting domestic biomanufacturing to ensure supply chain reliability. Yet for every bio-based product that reaches commercial success, countless others stall somewhere between the laboratory and the marketplace.  

 

The reality is that scaling a bio-based product is extraordinarily difficult. History is filled with well-funded ventures that have raised hundreds of millions of dollars and developed impressive technologies, but still failed to achieve sustainable market adoption. In many cases, the technology itself worked, the challenge was turning scientific success into commercial success.  

 

So, what separates the survivors from the graveyard?

Although every product and market is different, four elements consistently determine whether a bio-based innovation achieves long-term commercial success: performance, economics, supply chain security, and measurable sustainability. 

 

Performance Must Come First

Sustainability may be an initial market motivator, but consistent performance is what creates a truly successful product. 

 

A common misconception is that customers will accept lower performance in exchange for a more sustainable solution. There is also a tendency to overestimate customers' willingness to pay a premium for sustainability, which has proven difficult to achieve outside of select markets. 

 

In reality, most buyers are unwilling to compromise on functionality or pay more for sustainable goods. This is especially true when integrating a new material, ingredient, or chemical into an existing process.  

 

We have analyzed the different ways bio-based products can solve a problem at least as well as incumbent alternatives. In many cases, they solve it better. 

 

This is particularly important because adopting a new material often requires reformulation, qualification testing, commercialization efforts, and operational risk. If the bio-based alternative introduces uncertainty without delivering performance advantages, adoption slows considerably. 

 

Many early biomanufacturing ventures focused heavily on sustainability credentials while underestimating customer requirements around product performance and manufacturability. Commercial success requires starting with the end application and ensuring the final product meets or exceeds market expectations.  

 

Customers ultimately buy outcomes, not technologies.  

The most successful bio-based products provide a compelling combination of sustainability and performance that creates a compelling reason for customers to switch. 

 

Economics Drive Adoption

Even breakthrough science cannot overcome poor economics.

One of the most common reasons bio-based ventures fail is the assumption that customers will pay a significant "green premium" simply because a product is renewable or environmentally friendly. Customer purchasing data suggests otherwise. Many companies discovered as they attempted to commercialize that any premium customers were willing to pay was far smaller than anticipated.  

 

Commercial winners understand that economics must work at scale.

This does not necessarily mean matching the lowest-cost commodity alternative from day one. Instead, successful companies often begin in higher-value applications where performance or sustainability attributes justify differentiation. They prove their technology, optimize operations, improve yields, and gradually expand into larger markets over time.  

Economics must be considered early, not after commercialization begins. 

 

Techno-economic analysis, process scalability, feedstock availability, manufacturing costs, and logistics all play critical roles in determining whether a product can compete effectively. Products that look attractive in a laboratory may become economically unviable when scaled to commercial volumes.  

 

The organizations that find success are not necessarily those with the most innovative technology. They are often the organizations with the clearest understanding of how innovation translates into sustainable business economics. 

 

Supply Security Matters

Even the best-performing product at the right price can struggle if customers cannot depend on consistent supply. 

 

Reliability remains one of the most important purchasing criteria across industrial markets. Customers need confidence that suppliers can consistently provide products at the necessary quality, volume, and time frame. In many purchasing decisions, security of supply can be just as important as price.  

 

For bio-based products, supply security is often one of the biggest commercialization hurdles.

 

Production systems must move successfully from pilot reactors to full-scale manufacturing. Feedstocks must remain available and affordable. Supply chains must be resilient. Manufacturing facilities must operate reliably. 

 

Many biomanufacturing failures occurred because companies underestimated the complexity of scaling biological processes from thousands of liters to hundreds of thousands of liters while maintaining product quality and economic viability.  

 

Strategic partnerships frequently accelerate success by helping companies overcome these challenges. Established manufacturing partners, infrastructure providers, and experienced operators can dramatically reduce commercialization risk.  

 

As the bioeconomy continues to grow, customers will increasingly favor suppliers that can offer both innovation and security of supply. Commercial adoption dramatically improves when sustainability is paired with operational competence. 

 

Sustainability Must Be Measurable

Sustainability claims carry little weight if they cannot be quantified.

Customers, investors, regulators, and consumers increasingly expect evidence of environmental performance rather than broad sustainability statements. The ability to measure and verify impacts is becoming a prerequisite for market acceptance. 

 

This is especially true as companies commit to science-based decarbonization goals and broader sustainability commitments. Organizations need reliable data to support purchasing decisions, reporting requirements, and value chain emissions reductions.  

 

The most successful bio-based products connect sustainability outcomes to measurable metrics such as: 

 

• Product carbon footprint reduction 

• Renewable ingredients 

• Biodegradability or compostability 

• Resource and yield efficiency 

• Waste reduction 

• Supply chain resilience 

• Reduced dependency on petroleum-based ingredients and inputs 

 

When sustainability benefits can be clearly demonstrated, they become part of the overall value proposition rather than an abstract attribute. 

 

Importantly, measurable sustainability should complement performance and economics, not replace them. 

 

Customers consistently indicate that sustainability is important, but they still expect products to perform and remain commercially viable. Sustainability creates competitive advantage when it reinforces value rather than asking customers to accept trade-offs.  

 

The Path Forward for Bio-Based Products

The growth potential of the bioeconomy remains enormous. Economic analyses estimate that industrial bio-based products already represent the largest segment of the U.S. bioeconomy and are expected to continue growing in the years ahead. Growth is being driven by technology advancements, increasing customer demand, supply chain resilience priorities, and continued interest in sustainable alternatives.  

 

In addition to the four aforementioned elements, strategic innovation partners can make a meaningful difference in determining whether a bio-based product successfully reaches the market.  

 

Successfully commercializing a bio-based product rarely depends on innovation alone. Bringing a promising technology from the laboratory to reliable commercial production requires a combination of technical expertise, manufacturing capabilities, feedstock security, infrastructure, and market access. Strategic partnerships can help bridge the gap between process development, scale-up, and full commercial manufacturing while accelerating speed to market and reducing both capital requirements and execution risk.  

 

Just as importantly, the right partners can provide a clearer path to cost-competitive production and dependable customer supply, two factors that are essential for long-term adoption.  

 

Primient’s approach to partnership brings together process-development expertise, pilot- and demonstration-scale fermentation, downstream processing, integrated feedstocks, and commercial-scale manufacturing capabilities. By supporting multiple stages of the commercialization journey, Primient can help innovators reduce handoffs, manage scale-up risk, and move more efficiently toward reliable and economically viable products. 

 

Primient’s BioPDO™ provides an example of how the industry is evolving.  

With more than 20 years of commercial success, bio-PDO has helped formulators improve their end product while simultaneously reducing reliance on petroleum-derived ingredients. Bio-PDO is a 100% plant-based ingredient made from corn syrup through a proprietary industrial fermentation process, delivering a renewable alternative to petroleum-based materials.  

 

This bio-based material succeeded because it meets the fundamental requirements of any successful commercial product: it performs, it delivers value, it can be supplied reliably, and it provides measurable sustainability benefits. 

 

As the bioeconomy continues to grow, these same principles will determine which new innovations achieve lasting market impact. Bio-PDO serves as a reminder that sustainable products are most successful when sustainability becomes an enhancement to customer value, not a substitute for it.  

 

The next generation of bio-based products will succeed not because they are renewable, but because they deliver a compelling combination of performance, economics, supply security, and measurable sustainability outcomes. The future belongs to products that can do all four. 

 

Read more about Primient’s partnerships in our latest Impact Report.